Celldex Therapeutics (CLDX) Exchange Rate Effect (2010 - 2015)
Celldex Therapeutics (CLDX) posted quarterly Exchange Rate Effect of $15000.0 for Q1 2015, up 1400.0% year-over-year from $1000.0 in Q1 2014, and up 1600.0% quarter-over-quarter from -$1000.0 in Q4 2014.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Exchange Rate Effect (2010 - 2015) Analysis & Trends
Celldex Therapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $15000.0 for Q1 2015.
- In Q1 2015, Exchange Rate Effect rose 1400.0% year-over-year to $15000.0; the TTM figure through Dec 2015 stood at $15000.0 (up 400.0% YoY), while the FY2015 annual figure was $15000.0, up 400.0% from the prior year.
- Exchange Rate Effect for Q1 2015 stood at $15000.0, up from -$1000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $15000.0 in Q1 2015, with the low at -$4000.0 in Q1 2011.
- The 5-year median for Exchange Rate Effect is -$1000.0 (2011), against an average of $0.0.
- The sharpest annual moves came in 2011 and 2015: Exchange Rate Effect plunged 200.0% in 2011, then jumped 1400.0% in 2015.
- Celldex Therapeutics' Exchange Rate Effect stood at -$1000.0 in 2011, then surged by 200.0% to $1000.0 in 2012, then slumped by 200.0% to -$1000.0 in 2013, then changed by 0.0% to -$1000.0 in 2014, then jumped by 1600.0% to $15000.0 in 2015.
- Business Quant data shows CLDX's Exchange Rate Effect at $15000.0 in Q1 2015, -$1000.0 in Q4 2014, and -$3000.0 in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 10 | Celldex Therapeutics | 3.08 Bn | 3.08 Bn | -2.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 15,000.00 |
| Dec 31, 2014 | -1,000.00 |
| Sep 30, 2014 | -3,000.00 |
| Jun 30, 2014 | -2,000.00 |
| Mar 31, 2014 | 1,000.00 |
| Jun 30, 2013 | -1,000.00 |
| Mar 31, 2013 | -2,000.00 |
| Sep 30, 2012 | 1,000.00 |
| Jun 30, 2012 | -1,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Dec 31, 2011 | -1,000.00 |
| Sep 30, 2011 | -3,000.00 |
| Jun 30, 2011 | -1,000.00 |
| Mar 31, 2011 | -4,000.00 |
| Dec 31, 2010 | 1,000.00 |